Results 271 to 280 of about 1,080,451 (389)

Off-pump versus on-pump coronary-artery bypass grafting in elderly patients.

open access: yesNew England Journal of Medicine, 2013
A. Diegeler   +14 more
semanticscholar   +1 more source

Re‐PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long‐acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family ...
Marcin Ufnal   +9 more
wiley   +1 more source

Dacron femoropopliteal bypass grafts

open access: yesJournal of British Surgery, 1986
R. C. Kester   +3 more
openaire   +3 more sources

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

open access: yesESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang   +13 more
wiley   +1 more source

Combined Carotid Endarterectomy and off Pump Coronary Artery Bypass Grafting: A Case Report

open access: bronze, 1970
Saleh Ahmed Nurul Alam   +6 more
openalex   +2 more sources

Off-pump or on-pump coronary-artery bypass grafting at 30 days.

open access: yesNew England Journal of Medicine, 2012
A. Lamy   +24 more
semanticscholar   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

open access: yesESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy